Cardiovascular and Respiratory Safety Evaluation of Musca Domestica larvae Low Molecular Weight Peptide in Beagle Dogs.

BACKGROUND: Many studies have demonstrated that the water extracts and low-molecular-weight peptide (LMWP) of the Musca domestica larvae contain significant biological activity. However, the cardiovascular and respiratory safety evaluations of LMWP are yet to be sufficiently investigated.

AIM: The present study focused on the cardiovascular and respiratory safety evaluations of the M. domestica larvae LMWP in Beagle dogs.

METHODS: Direct cardiovascular and respiratory effects of three different doses of the M. domestica larvae LMWP were investigated following only once oral administration in conscious telemetered dogs, whereby ECG, arterial pressure, and respiratory data were collected using the Data Science International telemetric system.

RESULTS: The PR, QT, and QTcf intervals were significantly shortened in the medium-dose LMWP treatment group at 3 hours after drug administration. Furthermore, no significant differences were observed in any of the corresponding indexes of other treatment groups at different time points compared to those of the control group. P wave, ST segment, R wave, systolic pressure, diastolic pressure, and mean pressure were significantly different, although these differences had no significant dose-effect relationship. Respiratory frequency significantly increased in the medium-dose LMWP treatment group at 8 hours after drug administration compared to that of the control group. Respiratory rate and tidal volume showed no significant differences at varying time points among all LMWP treatment groups.

CONCLUSION: No toxicological effects related to cardiovascular and respiratory safety in Beagle dogs were observed at any dose level of the M. domestica larvae LMWP.